Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Simple vitamin pills could cut blood transfusions in pregnant african women

NCT ID NCT00148629

Prevention Sponsor: Cornell University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether adding daily multivitamins and an extra dose of deworming medication to standard prenatal care could prevent severe anemia in pregnant women in Zanzibar, Tanzania. Over 2,500 pregnant women took part, comparing the enhanced package to the usual WHO-recommended care. The goal was to reduce the need for blood transfusions and improve health for both mothers and babies.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
multivitamin and mebendazole (deworming drug)
What this could lead to
If successful, this could offer a simple, low-cost way to prevent severe anemia in pregnant women in resource-limited settings, reducing the need for blood transfusions and improving birth outcomes.
What could go wrong
This trial is completed but results may not apply to other regions or populations. The interventions are low-cost and low-risk, but the benefit may be modest compared to standard care alone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

2,500 people

Started

Apr 2004

Finished

Jan 2008

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Pregnant woman Exclusion Criteria: * Not a permanent resident of the community

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anemia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Birth Weight anemia prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Anemia Low birth weight Neonatal mortality

Contacts and locations

Locations

  • Public Health Laboratory "Ivo de Carneri"

    Wawi, Zanzibar, Tanzania

More trials for these conditions

Other studies related to the condition(s) this trial covers.